RxDoctor Payments Data

Nicolette Horbach, MD

Urogynecology and Reconstructive Pelvic Surgery · Annandale, VANPI 1407881790

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 97.3% of the total across 22 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 12 manufacturers, the largest accounting for just 17.2% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2021 at $243 and has fallen 53.7% since, to $112 in 2023. That places this record below the midpoint for urogynecology and reconstructive pelvic surgery clinicians in VA, where the typical reported total is $3,461.

$661in general payments, 2019–2025

Across 22 payments — averaging $30.04 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Renovia Inc$114
  • Axonics, Inc.$112
  • AbbVie$100
  • Pfizer$98
  • Caldera Medical, Inc$73
  • Therapeuticsmd, Inc.$45
  • plus $119 from 6 others

What the payments were for

  • Food & beverage$64397%
  • Education$183%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Renovia Inc2$114
Axonics, Inc.1$112
AbbVie(2 entities)5$100
Pfizer5$98
Caldera Medical, Inc1$73
Therapeuticsmd, Inc.2$45
Rochester Medical Corporation1$43
Coloplast1$18
AMAG Pharmaceuticals, Inc.1$18
Boston Scientific1$16
Ferring Pharmaceuticals Inc.1$13
Medtronic1$12

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$661 in reported general payments places this provider in the 15th percentile of 29 urogynecology and reconstructive pelvic surgery providers in Virginia.

See all urogynecology and reconstructive pelvic surgery providers in Virginia

Medicare billing

Part B allowed, 2024
$131,003
Medicare patients
165
Services billed
738

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Estradiol119$13,693
MyrbetriqMirabegron15$10,982
YuvafemEstradiol19$4,737
Solifenacin Succinate45$2,653
Nitrofurantoin Mono-MacroNitrofurantoin Monohyd/M-Cryst14$334

Paid to pharmacies, not to this prescriber.

Other urogynecology and reconstructive pelvic surgery in Annandale

See the full list for Virginia

Where these figures come from

Is this you, or does something look wrong? →